Kymera Therapeutics, Inc. (KYMR) Ownership

$44.79

$0.26 (0.58%)
Last update: 01:00 PM EST
Day's range
$44.26
Day's range
$45.15

Kymera Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
PRICE T ROWE ASSOCIATES INC /MD/ 05/14/2025 6.70 M $183.45 M   -2.44% 8.36%
AVORO CAPITAL ADVISORS LLC 05/15/2025 6.46 M $176.81 M   25.44% 8.06%
WELLINGTON MANAGEMENT GROUP LLP 05/13/2025 6.00 M $164.13 M   12.99% 7.48%
BAKER BROS. ADVISORS LP 05/15/2025 6.00 M $164.11 M   0.00% 7.48%
VANGUARD GROUP INC 05/09/2025 5.23 M $143.18 M   7.04% 6.53%
BVF INC/IL 05/15/2025 5.16 M $141.28 M   0.00% 6.44%
ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC 05/14/2025 4.90 M $134.02 M   0.00% 6.11%
FMR LLC 05/12/2025 4.41 M $120.68 M   -8.72% 5.50%
BLACKROCK, INC. 05/02/2025 4.28 M $117.22 M   -1.68% 5.34%
SIREN, L.L.C. 05/23/2025 3.24 M $88.69 M   9.11% 4.04%
STATE STREET CORP 05/15/2025 1.76 M $48.19 M   4.26% 2.20%
DRIEHAUS CAPITAL MANAGEMENT LLC 05/15/2025 1.17 M $31.99 M   -15.94% 1.46%
GEODE CAPITAL MANAGEMENT, LLC 05/13/2025 1.13 M $31.04 M   2.56% 1.41%
REDMILE GROUP, LLC 05/15/2025 983.41 K $26.92 M   -10.63% 1.23%
UBS ASSET MANAGEMENT AMERICAS INC 05/19/2025 896.40 K $24.53 M   121.52% 1.12%
ROCK SPRINGS CAPITAL MANAGEMENT LP 05/15/2025 794.44 K $21.74 M   -23.18% 0.99%
MERCK & CO., INC. 05/14/2025 772.17 K $21.13 M   0.00% 0.96%
JANUS HENDERSON GROUP PLC 05/15/2025 770.58 K $22.81 M   104.19% 0.96%
UBS GROUP AG 05/13/2025 593.61 K $16.25 M   26.34% 0.74%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 05/15/2025 593.00 K $16.23 M   0.00% 0.74%
JENNISON ASSOCIATES LLC 05/05/2025 552.29 K $15.12 M   -22.97% 0.69%
WOODLINE PARTNERS LP 05/15/2025 525.25 K $14.38 M   -2.27% 0.66%
EVENTIDE ASSET MANAGEMENT, LLC 05/15/2025 525.14 K $14.37 M   15.23% 0.66%
MILLENNIUM MANAGEMENT LLC 05/15/2025 510.48 K $13.97 M   340.38% 0.64%
AJU IB INVESTMENT CO., LTD. 04/08/2025 457.06 K $12.51 M   0.00% 0.57%
NORTHERN TRUST CORP 05/13/2025 421.66 K $11.54 M   -3.69% 0.53%
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 05/02/2025 420.05 K $11.50 M   0.13% 0.52%
DEER MANAGEMENT CO. LLC 05/15/2025 415.90 K $11.38 M   0.00% 0.52%
DIMENSIONAL FUND ADVISORS LP 05/13/2025 395.47 K $10.83 M   -8.83% 0.49%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/09/2025 381.71 K $10.45 M   -1.42% 0.48%
CAPITAL RESEARCH GLOBAL INVESTORS 05/12/2025 365.19 K $10.00 M   100.00% 0.46%
GOLDMAN SACHS GROUP INC 06/27/2025 344.24 K $9.42 M   -20.67% 0.43%
05/15/2025 325.00 K $8.90 M   -23.53% 0.41%
GILDER GAGNON HOWE & CO LLC 05/15/2025 318.38 K $8.71 M   -2.44% 0.40%
TD ASSET MANAGEMENT INC 05/07/2025 202.09 K $5.53 M   -11.58% 0.25%
MARSHALL WACE, LLP 05/15/2025 201.90 K $5.53 M   2,853.91% 0.25%
TWO SIGMA ADVISERS, LP 05/15/2025 183.30 K $5.02 M   -29.58% 0.23%
IKARIAN CAPITAL, LLC 05/15/2025 176.80 K $4.84 M   100.00% 0.22%
MORGAN STANLEY 05/15/2025 172.08 K $4.71 M   -28.23% 0.21%
SCHRODER INVESTMENT MANAGEMENT GROUP 05/13/2025 158.34 K $4.69 M   -3.39% 0.20%
TWO SIGMA INVESTMENTS, LP 05/15/2025 147.62 K $4.04 M   -15.04% 0.18%
FORESITE CAPITAL MANAGEMENT VI LLC 05/15/2025 146.33 K $4.01 M   0.00% 0.18%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 05/15/2025 144.22 K $3.95 M   -2.05% 0.18%
05/12/2025 143.24 K $3.92 M   100.00% 0.18%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 05/15/2025 142.59 K $3.90 M   -3.20% 0.18%
PATIENT SQUARE CAPITAL LP 05/14/2025 142.20 K $3.89 M   100.00% 0.18%
AQUILO CAPITAL MANAGEMENT, LLC 05/15/2025 138.52 K $3.79 M   -24.52% 0.17%
CHECKPOINT CAPITAL L.P. 05/15/2025 136.61 K $3.74 M   76.18% 0.17%
FRONTIER CAPITAL MANAGEMENT CO LLC 05/15/2025 131.96 K $3.61 M   -12.13% 0.16%
BANK OF NEW YORK MELLON CORP 04/29/2025 126.88 K $3.47 M   -0.17% 0.16%

Kymera Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 203 institutional investors and hedge funds held shares of Kymera Therapeutics, Inc.. The most heavily invested institutionals were:

PRICE T ROWE ASSOCIATES INC /MD/: 6.7 M

Avoro Capital Advisors LLC: 6.46 M

WELLINGTON MANAGEMENT GROUP LLP: 6 M

BAKER BROS. ADVISORS LP: 6 M

VANGUARD GROUP INC: 5.23 M

BVF INC/IL: 5.16 M

90.84% of Kymera Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 77.99 M shares in the last 24 months. This purchase volume represents approximately $3.49 B in transactions.